“EFFICACY OF NEWER GLP-1 RECEPTOR AGONISTS ON NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETES”. 2025. The Research of Medical Science Review 3 (5): 290-94. http://thermsr.com/index.php/Journal/article/view/1109.